GlobeStar Therapeutics (GSTC) Financial Statements

17 Followers

GlobeStar Therapeutics Financial Overview

GlobeStar Therapeutics's market cap is currently $1.24K. The company's EPS TTM is $-0.0008; its P/E ratio is -0.04; GlobeStar Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 77.00	$ 425.00
Gross Profit	$ 0.00	$ 0.00	$ -2.41K	$ -37.60K	$ 271.00
Operating Income	$ -1.86M	$ -1.26M	$ -9.09M	$ -304.00K	$ -316.00K
EBITDA	$ 6.72K	$ -1.26M	$ -9.09M	$ -302.00K	$ -314.00K
Net Income	$ -1.95M	$ -1.49M	$ -9.80M	$ -542.00K	$ -675.00K
Balance Sheet
Cash & Short-Term Investments	$ 0.00	$ 6.37K	$ 5.96K	$ 81.44K	$ 100.46K
Total Assets	$ 0.00	$ 9.91K	$ 5.96K	$ 89.91K	$ 142.18K
Total Debt	$ 366.00K	$ 20.00K	$ 106.13K	$ 155.08K	$ 113.80K
Net Debt	$ 366.00K	$ 13.63K	$ 100.17K	$ 73.64K	$ 13.34K
Total Liabilities	$ 1.43M	$ 1.20M	$ 731.78K	$ 749.13K	$ 827.62K
Stockholders' Equity	$ -1.43M	$ -1.19M	$ -725.82K	$ -659.22K	$ -685.43K
Cash Flow
Free Cash Flow	$ -205.76K	$ -327.00K	$ -751.23K	$ -241.52K	$ -260.14K
Operating Cash Flow	$ -205.76K	$ -327.00K	$ -751.23K	$ -239.74K	$ -260.14K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ -1.78K	$ 0.00
Financing Cash Flow	$ 199.40K	$ 327.40K	$ 675.75K	$ 222.50K	$ 269.00K

Currency in USD

GlobeStar Therapeutics Earnings and Revenue History

Income Statement >

GlobeStar Therapeutics Debt to Assets

Balance Sheet >

GlobeStar Therapeutics Cash Flow

Cash Flow >

GlobeStar Therapeutics Forecast EPS vs Actual EPS

Earnings >